New hope for kids with tough leukemia: first thai trial of advanced cell therapy

NCT ID NCT07078929

Summary

This is a first-in-Thailand study testing a new type of CAR-T cell therapy in children whose B-cell leukemia has come back or hasn't responded to standard treatments. Doctors will take a child's own immune cells, modify them in a lab to better target cancer, and infuse them back to fight the disease. The main goal of this early-phase trial is to check if the treatment is safe and to look for initial signs that it can control the cancer.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RELAPSE B ACUTE LYMPHOBLASTIC LEUKEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • King Chulalongkorn Memorial Hospital

    RECRUITING

    Bangkok, Pathumwan, 10330, Thailand

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

  • Maharaj Nakorn Chiang Mai Hospital

    NOT_YET_RECRUITING

    Chiang Mai, Mueang Chiang Mai District, 50200, Thailand

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Siriraj Hospital

    NOT_YET_RECRUITING

    Bangkok, Bangkoknoi, 10700, Thailand

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.